Author:
Brown Jennifer,Evans T. R. Jeffry
Publisher
Springer Berlin Heidelberg
Reference96 articles.
1. Alberts SR, Townley PM, Goldberg RM et al (2002) Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group Phase I study. Ann Oncol 13:553–557
2. Alberts SR, Townley PM, Goldberg RM et al (2003) Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Ann Oncol 14:580–585
3. Almoguerra C, Shibata D, Forrester K et al (1998) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53:549–554
4. Baker CH, Solorzano CC, Fidler IJ (2002) Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res 62:1996–2003
5. Barone C, Cassano A, Corsi DC et al (2003) Weekly gemcitabine and 24-hour infusional 5-fluorouracil in advanced pancreatic cancer: a phase I–II study. Oncology 64:139–145